Targeting STING pathways for the treatment of cancer

OncoImmunology

Volumn 4, Issue 12, 2015, Pages

  Gravekamp, Claudia ^a   Chandra, Dinesh ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

c di GMP; IL 12; Listeria Mage b; metastatic breast cancer; STING ligand

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; CASPASE 3; CD86 ANTIGEN; CYCLIC DIGUANYLATE; CYCLIC GMP DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 12; LISTERIA MAGE B VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; STIMULATOR OF INTERFERON GENES PROTEIN; SURVIVIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DRUG TARGETING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL;

EID: 84944522894     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.988463     Document Type: Article

References (10)

1. D.Amikam, M.Benziman. Cyclic diguanylic acid and cellulose synthesis in Agrobacterium tumefaciens. J Bacteriol 1989; 171(12):6649-55; PMID:2556370
2. D.K.Karaolis, T.K.Means, D.Yang, M.Takahashi, T.Yoshimura, E.Muraille, Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol 2007; 178(4):2171-81; http://dx.doi.org/10.4049/jimmunol.178.4.2171
3. D.L.Burdette, K.M.Monroe, K.Sotelo-Troha, J.S.Iwig, B.Eckert, M.Hyodo, Y.Hayakawa, R.E.Vance. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011; 478(7370):515-8; PMID:21947006; http://dx.doi.org/10.1038/nature10429
4. J.Wu, L.Sun, X.Chen, F.Du, H.Shi, C.Chen, Z.J.Chen. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013; 339(6121):826-30; PMID:23258412; http://dx.doi.org/10.1126/science.1229963
5. H.Ishikawa, G.N.Barber. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455(7213):674-8; PMID:18724357; http://dx.doi.org/10.1038/nature07317.
6. G.N.Barber. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 2011; 23(1):10-20; PMID:21239155; http://dx.doi.org/10.1016/j.coi.2010.12.015
7. D.Chandra, W.Quispe-Tintaya, A.Jahangir, D.Asafu-Adjei, I.Ramos, H.O.Sintim, J.Zhou, Y.Hayakawa, D.K.Karaolis, C.Gravekamp. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer. Cancer Immunol Res 2014; 2(9):901-10; PMID:24913717; http://dx.doi.org/10.1158/2326-6066.CIR-13-0123
8. S.H.Kim, F.Castro, D.Gonzalez, P.C.Maciag, Y.Paterson, C.Gravekamp. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. British J Cancer 2008; 99(5):741-9; PMID:18728665; http://dx.doi.org/10.1038/sj.bjc.6604526
9. A.Gomez-Cabrero, W.Wrasidlo, R.A.Reisfeld. IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model. PloS One 2013; 8(8):e73607; PMID:24014113; http://dx.doi.org/10.1371/journal.pone.0073607
10. M.B.Fuertes, A.K.Kacha, J.Kline, S.R.Woo, D.M.Kranz, K.M.Murphy, T.F.Gajewski. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med 2011; 208(10):2005-16; PMID:21930765; http://dx.doi.org/10.1084/jem.20101159